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In adenovirus particles, the viral nucleoprotein is organized into a highly compacted core structure. Upon delivery to the nucleus, the viral
nucleoprotein is very likely to be remodeled to a form accessible to the transcription and replication machinery. Viral protein VII binds to intra-
nuclear viral DNA, as do at least two cellular proteins, SET/TAF-Iβ and pp32, components of a chromatin assembly complex that is implicated in
template remodeling. We showed previously that viral DNA–protein complexes released from infecting particles were sensitive to shearing after
cross-linking with formaldehyde, presumably after transport of the genome into the nucleus. We report here the application of equilibrium-density
gradient centrifugation to the analysis of the fate of these complexes. Most of the incoming protein VII was recovered in a form that was not cross-
linked to viral DNA. This release of protein VII, as well as the binding of SET/TAF-Iβ and cellular transcription factors to the viral chromatin, did
not require de novo viral gene expression. The distinct density profiles of viral DNA complexes containing protein VII, compared to those
containing SET/TAF-Iβ or transcription factors, were consistent with the notion that the assembly of early viral chromatin requires both the
association of SET/TAF-1β and the release of protein VII.
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In adenovirus 5 particles, the viral DNA is organized into a
highly compact nucleoprotein core (Brown et al., 1975). Virion
proteins IVa2, V, VII, and Mu, along with the covalently
attached terminal protein (Tp), are components of the core
(Laver et al., 1968; Maizel et al., 1968; Prage et al., 1968, 1970;
Russell et al., 1968; Laver, 1970; Prage and Pettersson, 1971;
Russell et al., 1971; Everitt et al., 1973; Robinson et al., 1973;
Hosokawa and Sung, 1976; Amin et al., 1977; Rekosh et al.,
1977; Weber et al., 1983, Winter and D'Halluin, 1991; Zhang
and Imperiale, 2000, 2003; Zhang et al., 2001; Ostapchuk et al.,
2005). Tp is linked covalently to the 5′ end of each DNA strand
(Rekosh et al., 1977) and IVa2 binding is probably confined to
the encapsidation sequences (Zhang and Imperiale, 2000, 2003;
Zhang et al., 2001; Ostapchuk et al., 2005). In contrast, the basic
proteins V, VII, and mu are likely to provide general structure to
the viral nucleoprotein. The major core protein VII is tightly⁎ Fax: +1 717 531 4600.
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doi:10.1016/j.virol.2006.09.005associated with the viral DNA (Brown et al., 1975; Vayda et al.,
1983; Chatterjee et al., 1986). Protein V makes contacts both
with DNA and other core proteins (Chatterjee et al., 1985,
1986). Mu also binds strongly to double-stranded DNA
(Anderson et al., 1989).
The execution of the viral genetic program requires delivery
of the virion DNA to the nucleus. Partially uncoated virions
accumulate at the nuclear envelope for transport of the genome
into the nucleus through the nuclear pore complex (Greber et al.,
1997; Nakano and Greber, 2000; Trotman et al., 2001). The core
proteins enter the nucleus with the Tp–DNA complex; whether
their nuclear or nucleolar targeting signals (Matthews and
Russell, 1998; Matthews, 2001; Lee et al., 2003, 2004) have a
role in entry of infecting virions, other early events, or only later
after infection when the precursors are newly synthesized
(Everitt et al., 1971; Anderson et al., 1973; Ishibashi and
Maizel, 1974; Walter and Maizel, 1974; Weber, 1976), is not
known. Protein VII binds to intra-nuclear viral DNA (Chatterjee
and Flint, 1986; Haruki et al., 2003; Johnson et al., 2004).
Protein VII-containing “nuclear dots” are detected by immuno-
fluorescent staining, and these structures have been interpreted
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et al., 2005). Protein V has not been reported to associate with
intra-nuclear viral genomes. It has nucleolar targeting signals
and is excluded from infected cell structures that have properties
expected of viral DNA replication complexes (Matthews and
Russell, 1998). The small size of Mu and the lack of specific
antisera have precluded investigations of its fate in the nucleus,
although Mu-GFP also is excluded from the putative replication
complexes (Lee et al., 2004).
Upon delivery to the nucleus, the viral nucleoprotein is
undoubtedly remodeled from the compact form in the virion to a
form more accessible to transcription and replication machinery.
The DNA-binding properties of protein VII (Black and Center,
1979) suggest strongly that retention of an extensive association
with intra-nuclear viral DNA is problematic for expression from,
and copying of, the template. Supporting this view, injected
protein VII condenses and silences lampbrush chromosomes in
Xenopus oocyte nuclei (Johnson et al., 2004). Recent evidence
implicates host cell activities in the remodeling process. Protein
VII associates in vitro with two cellular proteins, SET/TAF-Iβ
(von Lindern et al., 1992; Nagata et al., 1995) and pp32 (Malek
et al., 1990), both of which also can be cross-linked to nuclear
viral DNA in early-infected cells (Haruki et al., 2003; Xue et al.,
2005). These cellular proteins are components of multi-protein
complexes, at least one of which (INHAT) has chromatin
assembly or remodeling activity (Brennan et al., 2000; Beresford
et al., 2001; Seo et al., 2001; Fan et al., 2003). In vitro, SET/TAF-
Iβ stimulates RNA synthesis from adenovirus cores as well as
chromatin templates (Matsumoto et al., 1995; Okuwaki and
Nagata, 1998). SET/TAF-Iβ also co-localizes with protein VII in
the nucleus and the cellular protein is required for normal timing
of the accumulation of some early viral RNAs (Haruki et al.,
2006). These findings suggest that the INHAT complex or its
components participate in remodeling of viral genomes (Haruki
et al., 2003).Fig. 1. Strategy for analysis of intra-nuclearProtein VII also associates in vitro with the adenovirus
transcriptional trans-activator E1a 289R (Johnson et al., 2004),
which is encoded by the first viral gene expressed in infected
cells (Berk et al., 1979; Jones and Shenk, 1979a; Nevins et al.,
1979; Ricciardi et al., 1981). E1a 289R could activate viral
transcription at least in part by altering the protein VII–viral
DNA interaction.
We previously reported the application of rate-zonal and
equilibrium-density gradient centrifugation to the analysis of
cross-linked and sheared viral DNA–protein complexes from
early-infected cells (Spector et al., 2003). Here we exploit these
techniques to examine the fate of protein VII and the structure of
intra-nuclear viral DNA in early-infected cells. We show that
most of the protein VII released from particles dissociated from
the viral genome soon after infection. The release of VII, as well
as the binding of SET/TAF-Iβ and cellular transcription factors
to the viral chromatin, did not require de novo viral gene
expression. The density profiles of viral DNA complexes
containing SET/TAF-Iβ and transcription factors were distinct
from the profiles of DNA–protein complexes containing protein
VII, consistent with the notion that the assembly of early viral
chromatin requires both the association of SET/TAF-1β and the
release of protein VII.
Results
To isolate and analyze complexes containing viral DNA
from infecting virions associated with proteins in the nuclei of
early-infected cells (intra-nuclear viral genomes), the protocol
shown in Fig. 1 was used. Formaldehyde cross-linked material
from infected cells (see Materials and methods) yields early
viral DNA–protein complexes of two kinds, shear-resistant and
shear-sensitive (Spector et al., 2003). The resistant material is
probably partially uncoated virions, whereas the shear-sensitive
material is probably intra-nuclear viral genomes (Spector et al.,viral chromatin. For details, see the text.
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along with cellular chromatin and other slow sedimenting
constituents of the cross-linked extracts, by sedimentation over
a 20% sucrose cushion. Pooled fractions from near the top of the
gradient that contained the sheared viral and cellular chromatin
were analyzed directly by ChIP, immunoblotting, or PCR (Fig.
1, 1). After density gradient centrifugation of the material in
these fractions (Fig. 1, 2), similar analyses provided additional
diagnostic information and served as a standard for comparison
to other conditions or mutant–virus infections.
The results of a typical density gradient analysis are shown in
Figs. 2 and 3. To perform the analysis shown in Fig. 2, total
DNAwas purified from each fraction after reversal of the cross-
links and assayed by PCR. As described in Materials and
methods, the quantification of PCR products was performed
under conditions that probably did not produce a strictly linearFig. 2. Density profiles of viral and cellular chromatin from early-infected cells.
HeLa cells were infected with dl309 (MOI 50) for 4.25 h and treated with
formaldehyde. Sheared chromatin was prepared, isolated from a sucrose
gradient, and fractionated by density gradient centrifugation (Fig. 1, protocol 2)
as described in Materials and methods. The cross-links were reversed and DNA
was purified from each fraction. The distribution of cellular DNA was
determined by PCR with HPV primers to amplify the human papillomavirus
sequences integrated into the HeLa cell genome (top panel). The distribution of
viral DNAwas determined by PCR with MLP primers (bottom panel). The solid
line is the profile of DNA and the dotted line is the density profile of the
fractions. An inverted image of the ethidium bromide-stained agarose gel is
shown below each profile.
Fig. 3. Density profiles of viral DNA–protein complexes from early-infected
cells. Fractions from equilibrium density gradients of dl309-infected samples
prepared as in the experiment described in the legend to Fig. 2 were subjected to
ChIP analysis with antibodies against the proteins indicated. DNAwas extracted
from the precipitated complexes and assayed by PCR using MLP primers. The
solid lines and dotted lines are as in Fig. 2.response to specific DNA concentration, but the profiles were
an accurate representation of the location of the peaks and
valleys of the particular DNA in the gradients.
The human papillomavirus type 18 (HPV) DNA in HeLa
cells provided a convenient marker for cellular chromatin. The
peak density of HPV DNA-containing chromatin was at about
1.43 g/ml, slightly higher than that expected for bulk cellular
chromatin (Fig. 2, top panel). As observed previously (Spector
et al., 2003), a substantial component of the adenovirus
chromatin had a protein content that was less than that of
bulk cellular chromatin and thus was recovered in the denser
fractions (Fig. 2, bottom panel).
To identify proteins bound to the viral DNA, antibodies to
protein VII, SET/TAF-Iβ (hereafter, referred to as SET), and a
cellular transcription factor, USF-1, were used for chromatin
immunoprecipitation (ChIP) assays (Fig. 3). For protein VII and
Fig. 4. Density profiles of protein VII in chromatin-containing samples from
early-infected cells. Samples from dl309-infected cells, cross-linked for 10 or
30 min, or dl312-infected cells cross-linked for 10 min, were prepared for
density gradients as in the experiment described in the legend to Fig. 2. After
fractionation, the cross-links were reversed and the distribution of total protein
VII was determined by electrophoresis of the proteins recovered from each
fraction and immunoblotting with antibody to protein VII. The bottom panel is a
long exposure of a gel from a sample prepared exactly the same as the one that
produced the data shown in the top panel, but from a different experiment.
Molecular weight markers in a separate lane (not shown) were used to verify the
expected migration of protein VII.
Fig. 5. Density profile of SET/TAF-Iβ in chromatin-containing samples from
early-infected cells. Left panel: dl309-infected cells were cross-linked for
10 min and chromatin samples were processed as described in the legend to Fig.
4. Right panel: HeLa cells were infected with dl309 (Ad5, MOI 50) or mock-
infected (M) and cross-linked for 10 min, and shear-sensitive chromatin was
isolated from a sucrose cushion. Without any further fractionation (protocol 1 in
Fig. 1), the cross-links were reversed and the proteins were separated by gel
electrophoresis. For both experiments, blots were prepared and probed with
antibody to SET/TAF-Iβ. The designations of the different SET/TAF proteins
were assigned based on molecular weight markers in a separate lane (not
shown).
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complexes. SET–DNA complexes were observed mostly in
the denser fractions (Fig. 3, bottom), whereas most complexes
containing protein VII and viral DNA had a greater protein
content (higher protein: DNA ratio) (Fig. 3, middle). To obtain a
statistical assessment of the apparent profile difference, the
proportion of the total ChIP signals in the profiles that were
observed in the dense fractions (1 and 2) was compared with the
proportion inmiddle fractions (4 and 5). Compared to the amount
of viral DNA co-precipitated with antibody to protein VII, the
dense fractions were enriched in viral DNA co-precipitated with
antibody to SET (p=0.02, n=5). In addition to the adenovirus
major late promoter region (MLP) shown in the figure, primers
for the L3 and E1b gene regions of viral DNA produced similar
profiles (data not shown). Thus, there was no evidence of a
preference for any particular viral DNA sequence in the profiles.
USF-1 binds to the MLP (Miyamoto et al., 1985; Sawadogo
and Roeder, 1985), which is active early in infection (Shaw and
Ziff, 1980). Detection of USF-1 cross-linked to the MLP served
as a sentinel for transcription factor binding to the early template.
As with the profile of viral DNA–SET complexes, more of the
complexes containing USF-1 usually were observed in the
denser, or protein-depleted (and VII-depleted), fractions of the
gradient (Fig. 3, top). Again, compared to the amount of viral
DNA co-precipitated with antibody to protein VII, the dense
fractions were enriched in viral DNA co-precipitated with
antibody to USF-1 (p=0.003, n=5). The USF-1 and SET
profiles were not distinguishable (p=0.34, n=5). A similar
profile was obtained for cellular transcription factor AP2 and
primers for the early region E1b gene promoter (data not shown).
Considered together, the results of the analyses shown in
Figs. 2 and 3 showed that the denser gradient fractions contained
a lower ratio of bound protein VII to total viral DNA than thelighter fractions. This finding suggested that a considerable
component of the nuclear viral DNAwas relatively depleted, at
least in part, of protein VII. If so, then free protein VII should be
detected near the top of the gradient where lighter density
proteins should sediment to equilibrium. Accordingly, the cross-
links were reversed and the total protein VII in each gradient
fraction was detected by immunoblotting. Most of the protein
VII was at the top of the gradient (Fig. 4). Longer exposures
revealed minor amounts of the protein in fractions that were
enriched in VII–DNA complexes as measured by the ChIP
assay. Since little or no ChIP signal was observed for protein VII
and viral DNA in the lightest gradient fractions (see Fig. 3), most
of the protein VII in the cross-linked and sheared material was
not associated with viral DNA.
The 10-minute standard cross-linking condition used here
might not have been sufficient to capture protein VII in viral
DNA complexes. Two controls were performed to examine this
possibility. First, the cross-linking time was increased to 30 min.
The distribution of protein VII in the top two fractions of the
gradient was altered slightly, but there was no significant
increase in capture of protein VII in DNA–protein complexes as
would be suggested by a substantial density change (Fig. 4).
Examining the profile of SET proteins in the gradients
provided a second control for cross-linking conditions (Fig. 5,
left panel). Since nuclear SET in the INHAT complex binds to
histones (Seo et al., 2001), one might expect that a substantial
amount of nuclear SET would cross-link to cellular chromatin
and that the protein would be recovered in fractions with an
increased density. The SET antibody detected three prominent
protein bands. The slowest migrating, at about 41 kDA, had the
electrophoretic mobility expected for the SET homologue
TAF-1α (Matsumoto et al., 1995; Nagata et al., 1995). A 38-
kDA species corresponded to SET/TAF-1β (Matsumoto et al.,
1995; Nagata et al., 1995). A 25-kDA protein had the mobility
expected of a nuclear product previously identified as a result of
Fig. 7. Lack of viral gene expression requirement for protein binding to the
adenovirus genome in early-infected cells. HeLa cells were infected with dl309
or dl312 (MOI 50, 4.25 h) and cross-linked for 10 min, and shear-sensitive
chromatin was isolated from a sucrose cushion. Without any further
fractionation (protocol 1 in Fig. 1), the cross-links were reversed and ChIP
was performed with antibodies to the proteins indicated. DNA was extracted
from the precipitated complexes and assayed by PCR using MLP primers. (−):
no antibody. IN: PCR of dilutions (1:200, 1:800, and 1:3200) of DNA isolated
directly from samples used for the ChIP assay.
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slower migrating forms were enriched in the fractions containing
the peak of cellular chromatin, as would be expected for these
two components of the INHATcomplex. In contrast, the cleaved
form was at the top of the gradient, as expected for a non-
chromatin binding cleavage product. These data indicate that the
cross-linking conditions were sufficient to convert most of the
SET into denser DNA-containing complexes. Together with the
results of the experiment with increased time of cross-linking,
these data show that failure to incorporate the majority of the
protein VII into more dense complexes was not due to in-
sufficient opportunity for the formaldehyde to cross-link proteins
to viral or cellular DNA.Fig. 6. Density profiles of viral DNA–protein complexes from cells infected with
dl312. Fractions from equilibrium density gradients of dl312-infected samples
prepared as in the experiment described in the legend to Fig. 2 were subjected to
ChIP analysis with antibodies against the proteins indicated. DNAwas extracted
from the precipitated complexes and assayed by PCR using MLP (USF-1) or
E1bg (VII and SET) primers. The solid lines and dotted lines are as in Fig. 2.We considered the possibility that viral infection might alter
the distribution of the different forms of the SET protein.
Accordingly, we compared the profiles of SET proteins in
blots from infected and uninfected cells (Fig. 5, right panel).
No difference was observed.
Viral chromatin remodeling and viral gene expression
The density profiles of viral DNA, protein VII and SET, and
viral DNA–protein complexes, that were characteristic of the
intra-nuclear chromatin derived from wild-type virus infection
indicated that extensive remodeling occurred subsequent to
delivery of the virion DNA to the nucleus. To determine
whether de novo viral gene expression is required for this
remodeling, we performed the cross-linking experiments with
mutant dl312, which has no E1a gene and expresses little if any
early viral proteins within the first six hours of infection (Jones
and Shenk, 1979a,b; Nevins et al., 1979). In addition to
examining the viral DNA (not shown), protein VII (Fig. 4), and
ChIP gradient profiles (Fig. 6), we also assayed protein binding
to viral DNA before density gradient separation (Fig. 7). In each
case, the results were similar to those obtained with wild-type
virus. With dl312, the ChIP density profiles of VII and SET
showed a trend toward a difference similar to that between the
wild-type profiles (p=0.10, n=3), whereas the profile with
USF-1 was clearly distinct from that with protein VII (p=0.03,
n=3). Again, the USF-1 and SET profiles were not distin-
guishable (p=0.39, n=3).
To evaluate the transcription activity of the dl312 chromatin,
ChIP was performed with antibodies to RNA polymerase IIFig. 8. Viral gene expression requirement for RNA polymerase II binding to the
adenovirus genome in early-infected cells. Samples were prepared and analyzed
as described in the legend to Fig. 7, except that antibodies to the proteins indicated
were used for the ChIP analysis and PCRwas performedwith L3 primers. (−): no
antibody. IN: as in the experiment described in the legend to Fig. 7.
Table 1
Viral gene expression requirement for RNA polymerase II binding to the
adenovirus genome in early-infected cellsa
Strain Expt # gene N20 C21 Ratiob
dl309 Ic E1b 3.2d 1.2 2.7
2.5 0.93 2.7
L3 2.0 0.83 2.4
2.0 0.88 2.3
II E1b 1.2 0.55 2.2
III L3 1.5 0.6 2.5
dl312 Ic E1b 0.91 0.50 1.8
L3 0.56 0.50 1.1
II E1b 1.4 1.6 0.88
III L3 1.4 1.0 1.4
a Samples were prepared and analyzed as described in the legend to Fig. 7,
except that antibodies to the N- or C-terminus of RNA polymerase II, an
irrelevant antibody, or no antibody was used for the ChIP analysis and PCR was
performed with E1b or L3 primers as indicated.
b N20/C21.
c The results of the first L3 determination from this experiment are shown in
Fig. 8.
d Scanned values were divided by the value obtained from a ChIP assay
performed with either an irrelevant antibody or no antibody.
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and L3 regions are transcribed early (Shaw and Ziff, 1980).
One of these antibodies, to the Pol II N-terminus, produced a
signal from wild-type virus samples (Fig. 8, Table 1), whereas
the other antibody, to the Pol II C-terminus, did not produce a
signal with wild-type virus. Neither antibody produced a signal
with dl312. Therefore, detectable Pol II binding to the intra-
nuclear viral templates did not accompany the remodeling of
dl312 chromatin.
Discussion
The results of these experiments can be summarized as
follows: In early-infected cells, heterogeneity in the density of
cross-linked, adenovirus DNA–protein complexes reflected not
only different protein–DNA ratios but also qualitatively
different protein compositions. Transcription factors and the
cellular protein SET were more likely than protein VII to be
contained in denser complexes. This evidence that protein VII
content was reduced in a substantial proportion of the viral
genomes was strengthened by the observation that most of the
protein VII was not cross-linked to viral DNA. Finally, at least
for the proteins examined, the composition of early viral
chromatin did not depend on de novo viral protein synthesis.
These conclusions were drawn from investigation of the
complete population of viral chromatin in the nucleus. The
fraction that is potentially active for transcription and
replication was not determined; however, there is evidence
that the fraction of viral DNA that enters the nucleus is within
the range of the fraction of particles capable of initiating
productive infection (Chatterjee and Flint, 1986).
The evidence for release of protein VII raises several issues
in light of other published data. One possible explanation for the
observation of protein VII-containing dots in the nuclei of early-
infected cells is that they represent individual viral genomes(Xue et al., 2005). If so, then what can be made of our finding
that most of the protein VII is not cross-linked to the DNA?
There are several non-mutually exclusive possibilities.
First, only a minor fraction of the protein VII may have
remained associated with most templates, but that amount
would be sufficient for detection by immunofluorescence. By
mass spectroscopy, the virion copy number for protein VII has
been estimated at about 640 (Lehmberg et al., 1999), somewhat
less than values derived from radiolabeling (Everitt et al., 1973;
van Oostrum and Burnett, 1985). Release of 90% or more of the
protein VII might leave enough to detect a signal by
immunofluorescence. A second possibility is that one portion
of templates retained a high copy number of protein VII and
produced the immunofluorescence signals, whereas a much
larger portion retained too little protein VII to produce signals.
Evidence for heterogeneity in the viral nucleoprotein is
consistent with this notion. The possibility that most of the
protein VII remained associated with viral DNA in a “loose”
configuration resistant to cross-linking cannot be excluded. Our
method would not have scored that protein VII as part of a DNA
complex. The nature of that association would have to be very
different from the kinds of interactions in chromatin, since the
same conditions converted most of the SET to a form with
increased density. It should be noted that, when the ability to
capture viral DNA is considered, protein VII–DNA complexes
were recovered much more efficiently than either SETor USF-1
complexes (Fig. 7).
If the protein VII that was not cross-linked to DNA is truly
released, what is its fate? At least some could be bound to SET
but not pp32. Protein VII co-localizes with SET in infected-cell
nuclei and the two proteins co-precipitate (Haruki et al., 2006).
Although pp32 binds to viral templates (Xue et al., 2005), it
does not co-localize or co-precipitate with protein VII (Haruki
et al., 2006). The released protein VII could account for some or
all of the nuclear dots (see above) and/or be difficult to detect
immunologically, perhaps because it is sequestered in a non-
reactive form. Displaced protein VII could have an important
role in the nucleus. In this regard, the reported potential for
association between protein VII and E1a (Johnson et al., 2004)
is intriguing. Although our results suggest that E1a binding to
protein VII is not required for template remodeling, the
interaction could participate in another important process in
early-infected cells. Displacement of protein VII also could
involve biochemical modifications. Virion protein VII has been
reported to be weakly phosphorylated (Axelrod, 1978;
Chatterjee et al., 1986). Since one of the activities of INHAT
complex proteins is the inhibition of protein phosphatase 2a (Li
et al., 1996), it will be important to determine whether intra-
nuclear VII is modified by a change in phosphorylation state or
in some other way.
Results with dl312 indicate that the initial remodeling of the
viral core structure to intra-nuclear complexes depleted in
protein VII and containing associated transcription factors did
not require de novo viral gene expression. On the other hand,
viral early protein synthesis may be required for the
establishment of other early template properties not assayed
here, for additional changes in template structure, or for non-
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nucleus.
We cannot exclude the possibility that at least some sequence
specificity contributed to the heterogeneity in the density of viral
DNA protein complexes. We did not probe comprehensively
with respect to the viral genome. Very little variation in the
association of protein VII and SET with most regions of the
genome has been reported, although there may be a particular
deficit in binding to the E1a promoter region (Haruki et al.,
2003).
These methods also did not provide either quantitative or
qualitative information about the properties of the transcriptionally
active viral chromatin. The signal-to-noise ratio of the ChIP assay
for RNApolymerase II was too low to obtain reproducible profiles
when probing gradient fractions for the Pol II-containing viral
DNA complexes (data not shown). Compared to preinitiation
complexes containing only transcription factors, active complexes
could have a reduced density due to the large protein mass
contributed by Pol II and its associated factors. Thus, although the
denser USF-1-containing complexes might be transcriptionally
competent, they might not be transcriptionally active.
If denser viral DNA complexes that were enriched for
transcription factors and/or SET are either precursors or active
for transcription, then it is unlikely that a cellular nucleosome-
like structure is a necessary end product of remodeling. Cross-
linked and sheared nucleosomal DNA has a density of about
1.40, less dense than most of the viral DNA complexes.
Although nuclease-sensitivity patterns of viral DNA from early-
infected nuclei were interpreted as consistent with a nucleo-
some-like structure (Sergeant et al., 1979; Tate and Philipson,
1979; Daniell et al., 1981; Dery et al., 1985), the results from
cross-linking failed to support this hypothesis (Chatterjee and
Flint, 1986). Whether assembly proteins other than SETor pp32
(Haruki et al., 2003; Xue et al., 2005) also bind to the viral
templates in infected cells has not been investigated.
These results are consistent with a model in which cellular
proteins participate in a default remodeling of virion nucleo-
protein either concomitant with, or shortly after, transport of the
genome and at least some of the core proteins into the nucleus.
The association of SET, perhaps as part of a nucleoprotein
assembly complex, with the template and the release of protein
VII would allow transcription factors to bind to the template and
initiate transcription. There is currently no evidence that SET
binds DNA directly in vivo. It is tempting to speculate that the
INHAT complex (Seo et al., 2001) drives the remodeling
process. In this scheme, the ability of INHAT components to
bind at least to protein VII (Haruki et al., 2003; Xue et al., 2005)
could provide the activities necessary to remove protein VII
from the DNA and assemble the DNA into a functional form.
Inhibition of SET would be expected to prevent normal
activation of early viral gene transcription as reported (Haruki
et al., 2006). At least in the initial stages of the transition, any
mechanism would seem to require protein VII and SET to form
ternary complexes with DNA, as has been observed in vitro
(Haruki et al., 2003). On the other hand, extensive coverage of
DNA by either protein could bemutually exclusive, as suggested
by the density profiles reported here.The analysis of early template interactions with viral and
cellular proteins in the absence of cross-linking would seem to
be critical for further investigation of the components of these
complexes. The association of the adenovirus genome with the
nuclear matrix (Bodnar et al., 1989; Schaack et al., 1990;
Fredman and Engler, 1993) will constitute a challenge to the
isolation and characterization of viral DNA-containing com-
plexes from early-infected cells.
Materials and methods
Cells and viruses
Monolayer and suspension cultures of HeLa cells and
monolayer cultures of 293 cells (Graham et al., 1977) were
maintained as described previously (Parks et al., 1988; Maxfield
and Spector, 1997). The origins of wild-type adenovirus strain
dl309 and the E1a-negative mutant strain dl312 have been
described (Jones and Shenk, 1979b). Adenovirus stocks were
prepared from infected HeLa cells growing in suspension or
infected 293 cells growing in monolayer culture (Spector and
Samaniego, 1995). Virus was purified by two cycles of cesium
chloride gradient centrifugation and quantified by plaque
titration on 293 cell monolayers (Parks and Spector, 1990;
Spector and Samaniego, 1995).
Antibodies
Rabbit polyclonal antisera to transcription factors USF-1 (sc-
229) or Sp-1 (sc-59), RNA polymerase II (sc-899, POLN; and
sc-900, POLC), or SET/TAF-Iβ/I2PP2A (sc-25564) were
obtained from Santa Cruz Biotechnology. Rabbit polyclonal
antiserum to protein VII was described previously (Johnson
et al., 2004). 0.4 or 2 μg of antiserum was used for chromatin
immunoprecipitation, whereas a 1:1000 dilution of antiserum
was used to probe immunoblots.
Peroxidase-conjugated goat IGG fraction to rabbit IGG
(whole molecule, Cappel No. 55676) was obtained from
Organon Teknika Corp. (Durham, NC) and used for secondary
immunoblot probing as described previously (Spector et al.,
2003).
Preparation and fractionation of cross-linked chromatin
Cross-linked chromatin was prepared from HeLa cells at
4.25 h post infection as described previously (Spector et al.,
2003) except that 0.033 volumes of 1 M HEPES, pH 7.1, was
added to the medium prior to addition of formaldehyde and
cross-linking was performed for 10 or 30 min. Material that was
resistant to extraction with 0.5% nonIdet P-40 and extensive
Dounce homogenization was collected by centrifugation at
1500 rpm in a CRU-5000 centrifuge (Damon/IEC) and subjected
to shearing by sonification. The sheared chromatin was
separated by rate-zonal centrifugation on a cushion of 20%
sucrose as described previously (Spector et al., 2003). The
second and third fractions (0.5 ml each) from the top of the tube,
containing the sheared viral chromatin, were pooled and
123D.J. Spector / Virology 359 (2007) 116–125adjusted to a density of about 1.39 g/ml for density gradient
analysis as described previously (Spector et al., 2003). Each
cesium chloride gradient contained material from about 5×107
cells.
Analysis of density gradient fractions
Density gradient fractions (0.5 ml) were dialyzed against two
changes of 500ml of 0.01MTris–HCl, pH, 8.0, 0.001MEDTA,
0.0005 M EGTA, and 5% glycerol (Orlando et al., 1997).
Aliquots were prepared for analysis by immunoblotting, PCR, or
chromatin immunoprecipitation (ChIP) as described previously
(Spector et al., 2003). The ChIP protocol was modified slightly
as follows: 0.06 ml of 50%BSA-protein A-Sepharose beads was
mixed with 0.5 mg of salmon sperm DNA in 1.0 ml of IP lysis
buffer for 4 h at 4°. The beads were collected and mixed with
0.15 ml of the gradient fraction in 1.0 ml of IP lysis buffer
(Samaniego et al., 1994) for 1 h at 4°. The beads were removed
by centrifugation and the chromatin was stored at−70° until use.
For ChIP, 0.15 ml of chromatin so prepared was adjusted to
0.5 ml with IP lysis buffer and incubated with antibody
overnight at 4°. Any precipitating material was removed by
centrifugation at 10,000 rpm for 10 min and the supernatant was
incubated for 1 h more with 0.03 μl of 30% protein A-Sepharose
beads. The beads were collected and processed as described
previously (Spector et al., 2003). Unfractionated chromatin from
the sucrose cushion was handled in a similar manner.
PCR reactions employed a cycle number that yielded visible
bands in ethidium bromide-stained agarose gels, but that was
sub-saturating for the samples that contained the highest
concentration of the amplified DNA sequences. In practice,
this condition was established by comparing the data obtained
using a cycle number that produced low intensity signals with
that obtained after increasing the cycle number by two. Similar
profiles were usually observed in both cases and more consistent
scanning was obtained from the higher cycle profile. However,
the relationship between the starting DNA concentration of these
sequences and band intensity was not strictly linear, with
underestimation of the actual amount in the samples with greater
concentrations of specific DNA.
Initial ChIP experiments to profile gradient fractions included
two kinds of controls. One was to ChIP each fraction in the
absence of antibody and the second was to assay ChIPped DNA
preparations by PCR using primers for an irrelevant viral DNA
region. The latter could only be conducted on samples
precipitated by anti-USF-1, since the anti-VII and anti-SET
antibodies precipitated all viral DNA regions. The maximum
intensities of the bands from the SET ChIP reactions were
usually about the same as the USF-1 signals, and the VII bands
were much stronger. Thus, the signal-to-noise determinations for
USF-1, as measured by these controls, were a useful indicator of
the potential contribution of background viral DNA recovery to
the profile characteristics. For both kinds of control experiments,
signal-to-noise ratios for individual fractions were at least five-,
and generally ten-fold, similar to the ratios reported previously
for unfractionated samples and anti-USF-1 (Spector et al., 2003).
These background levels did not contribute significantly to theprofile characteristics or the interpretation of the data and so the
background determinations were not routinely performed. ChIP
reactions were performed routinely on each unfractionated
chromatin sample to ensure that preclearing conditions were
sufficient to obtain the desirable signal-to-noise ratios.
PCR products were imaged with a Kodak EDAS 290 digital
camera. The bands were quantified using NIH Image v.1.62.
The background intensity produced by a lane containing a PCR
reaction with no added DNA was subtracted from each value.
Statistical analysis was performed using the paired, one-tailed,
Student's t-test.
PCR primers
Primer pairs for the adenovirus major late promoter (MLP)
and region L3 were described previously (Spector et al., 2003).
Human papillomavirus (HPV) type 18 E7/E1 region: nucleotides
747–772, 5′-GAGCCGAACCACAACGTCACACAATG-3′;
nucleotides 913–894, 5′-TGTTGCTTACTGCTGGGATG-3′.
Adenovirus E1b gene (E1bg): nucleotides 2608–2628, 5′-GTTG-
CTACATTTCTGGGAACG-3′; nucleotides 2859–2865, 5′ GA-
ACCCTTACATCGGTCCAGGCTT-3′.
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